Histopathological characteristics and viral association with HIV-associated Multicentric Castleman's Disease (MCD) and with classical Castleman's Disease (cCD)

被引：0
|
作者：
Kloster, J. [1 ]
Hoffmann, C. [2 ]
Tiemann, M. [3 ]
机构：
[1] UKSH Campus Kiel, Kiel, Germany
[2] UKSH Campus Kiel, ICH Study Ctr, Hamburg, Germany
[3] Inst Hamatopathol Hamburg, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P256
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [31] Rituximab-based therapies improve outcome of patients with HIV-associated multicentric Castleman's disease
    Hoffmann, C.
    Mueller, M.
    Teutsch, C.
    van Lunzen, J.
    Esser, S.
    Wolf, T.
    Wyen, C.
    Sabranski, M.
    Horst, H-A
    Reuter, S.
    Vogel, M.
    Jaeger, H.
    Bogner, J.
    Arasteh, K.
    Schmid, H.
    [J]. ONKOLOGIE, 2011, 34 : 22 - 22
  • [32] HIV-associated multicentric Castleman's disease after initiation of antiretroviral therapy: experience of a European centre
    Katchanov, J.
    Zimmermann, U.
    Branding, G.
    Arasteh, K.
    Mueller, M.
    [J]. INFECTION, 2014, 42 (04) : 791 - 793
  • [33] Rituximab induces long-term remissions in patients with HIV-associated multicentric Castleman's disease
    Bower, M.
    Powles, T.
    Williams, S.
    Newsom-Davis, T.
    Atkins, M.
    Stebbing, J.
    Montoto, S.
    Nelson, M.
    Webb, A.
    Kelleher, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Cutaneous vasculitis in HIV-associated Castleman's disease: a rare manifestation
    Kourkounti, Sofia
    Paparizos, Vasilios
    Retsas, Theodoros
    Dimitrakopoulou, Amerini
    Rigopoulos, Dimitrios
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (02) : 236 - 237
  • [35] Cutaneous vasculitis in HIV-associated Castleman’s disease: a rare manifestation
    Sofia Kourkounti
    Vasilios Paparizos
    Theodoros Retsas
    Amerini Dimitrakopoulou
    Dimitrios Rigopoulos
    [J]. European Journal of Dermatology, 2019, 29 : 236 - 237
  • [36] Idiopathic multicentric Castleman's disease
    Vasilyev, V., I
    Palshina, S. G.
    Pavlovskaya, A., I
    Kokosadze, N., V
    Chaltsev, B. D.
    Shornikova, L. A.
    [J]. TERAPEVTICHESKII ARKHIV, 2020, 92 (05): : 78 - +
  • [37] Multicentric Castleman's disease in Malawi
    Gopal, Satish
    Fedoriw, Yuri
    Montgomery, Nathan D.
    Kampani, Coxcilly
    Krysiak, Robert
    Sanders, Marcia K.
    Dittmer, Dirk P.
    Liomba, N. George
    [J]. LANCET, 2014, 384 (9948): : 1158 - 1158
  • [38] Efficacy of siltuximab in patients with previously treated multicentric Castleman's disease (MCD).
    Van Rhee, Frits
    Munshi, Nikhil C.
    Wong, Raymond
    Ke, Xiaoyan
    Fossa, Alexander
    Simpson, David
    Dispenzieri, Angela
    Lechowicz, Mary Jo
    Kuruvilla, John
    Bandekar, Rajesh
    Qin, Xiang
    Qi, Ming
    Vermeulen, Jessica
    Casper, Corey
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] A RARE DISEASE ASSOCIATED WITH HIV: CASTLEMAN'S DISEASE
    Melnick, Stephen
    Basnet, Sijan
    Abdulkareem, Abdullateef
    Forman, Daniel
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S433 - S433
  • [40] Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease
    Gerard, Laurence
    Michot, Jean-Marie
    Burcheri, Sara
    Fieschi, Claire
    Longuet, Pacale
    Delcey, Veronique
    Meignin, Veronique
    Agbalika, Felix
    Chevret, Sylvie
    Oksenhendler, Eric
    Galicier, Lionel
    [J]. BLOOD, 2012, 119 (10) : 2228 - 2233
12345